Wholomics GmbH

We are a young startup founded by biochemists and IT experts from UCL, and MIT/TUM who developed a novel method for early cancer detection - based on a simple blood draw. Our vision is to improve patient lives by transforming the diagnosis of cancer from a death sentence to a grasp of hope - Hope, since we detect it early enough to intercept.

We are focussing on #1 of the deadliest cancers in the world, pancreatic cancer. Since it is usually detected at late stages, when survival rates already dropped dramatically and only a few therapies are available, we addressed this unmet medical need and came up with a new method of detecting pancreatic cancer early - from stage IA on. We are currently working on expanding our method to other cancer types.